 If Anticorps anti-CCP and rheumatoid factor are part of the diagnostic criteria, anti-nuclear antibody are found in 15 to 40%.
Objectifs of our study : Studying the immunological profile in 110 patients treated for rheumatoid arthritis Cross-sectional descriptive study of 110 cases of rhumatoid arthritis, defines according ARA and EULAR criteria  Patients followed in the rheumatology department, in consultation or hospitalization  The study of immunological profile, including rheumatoid factor (RF), anti-CCP antibody (ACPA) and antinuclear antibodies (ANA) were analyzed for all patients.
Rheumatoid factor positive when > 1/64 by agglutinin or 20 UI by Elisa method.
 AAN positif when > 1/80.
 And ACPA considerated significativly positif when exced 50 UI.
 Rheumatoid arthritis (RA) : Chronic inflammatory disease that affects approximately 1% of the worldwide population.
 It primarily targets synovial membrane of joints Leading to a synovial proliferation, joint cartilage lesion and erosions in the adjacent bone tissue.
 The disease, usually progressive and if the inflammatory process is not adequately suppressed  Joint deformity takes place, leading to a significant functional disability and work incapacity.
 Despite the growing number of biological agents with different immunological targets  Significant number of patients do not receive appropriate disease control or have the use of these agents limited because of adverse events  Antibody anti-CCP and rheumatoid factor are part of the diagnostic criteria also anti-nuclear antibody are found in 15 to 40%.
 Our study is superimposed on the literature, anti-nuclear antibody were positive in 26% of cases. Patients were female predominantly (87.2%).
 Mean duration of rhumatism arthritis was 8 years.
 Regarding the immunological profile, all patients had rheumatoid factor and antinuclear antibody, except two respectively.
The antibody anti CCP were performed in 70% of patients.
 ANA were positive in 26% of cases.
 Rheumatoid factor positive in 73% of cases,  Anti CCP were realized for 77 cases, were positive in 74% of patients.
 Among the patients with 3 parameters made (77 cases), all were positive in 11 cases (14.3%)
 Anti CCP and rheumatoid factor positive in 32 cases (41.5%).
